nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—ALB—focal segmental glomerulosclerosis	0.364	1	CbGaD
Zidovudine—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.114	0.268	CbGbCtD
Zidovudine—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.0924	0.217	CbGbCtD
Zidovudine—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0608	0.143	CbGbCtD
Zidovudine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.051	0.12	CbGbCtD
Zidovudine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0424	0.0994	CbGbCtD
Zidovudine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0412	0.0965	CbGbCtD
Zidovudine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0247	0.0578	CbGbCtD
Zidovudine—SLC22A2—nephron—focal segmental glomerulosclerosis	0.012	0.139	CbGeAlD
Zidovudine—SLC28A1—nephron tubule—focal segmental glomerulosclerosis	0.00814	0.0938	CbGeAlD
Zidovudine—SLC22A8—nephron—focal segmental glomerulosclerosis	0.00782	0.0901	CbGeAlD
Zidovudine—Breath sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00772	0.0765	CcSEcCtD
Zidovudine—SLC28A1—kidney—focal segmental glomerulosclerosis	0.00715	0.0824	CbGeAlD
Zidovudine—SLC28A1—cortex of kidney—focal segmental glomerulosclerosis	0.00696	0.0803	CbGeAlD
Zidovudine—Swollen tongue—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.0499	CcSEcCtD
Zidovudine—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.0439	CcSEcCtD
Zidovudine—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.0299	CcSEcCtD
Zidovudine—SLC22A11—nephron tubule—focal segmental glomerulosclerosis	0.00299	0.0345	CbGeAlD
Zidovudine—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00282	0.0325	CbGeAlD
Zidovudine—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.0272	CcSEcCtD
Zidovudine—UGT2B7—kidney—focal segmental glomerulosclerosis	0.0027	0.0311	CbGeAlD
Zidovudine—SLC22A11—kidney—focal segmental glomerulosclerosis	0.00263	0.0303	CbGeAlD
Zidovudine—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.0258	CcSEcCtD
Zidovudine—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.0026	0.03	CbGeAlD
Zidovudine—SLC22A7—kidney—focal segmental glomerulosclerosis	0.00257	0.0296	CbGeAlD
Zidovudine—SLC22A11—cortex of kidney—focal segmental glomerulosclerosis	0.00256	0.0295	CbGeAlD
Zidovudine—SLC22A7—cortex of kidney—focal segmental glomerulosclerosis	0.0025	0.0288	CbGeAlD
Zidovudine—ABCC5—nephron tubule—focal segmental glomerulosclerosis	0.00245	0.0283	CbGeAlD
Zidovudine—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00241	0.0278	CbGeAlD
Zidovudine—SLC22A2—kidney—focal segmental glomerulosclerosis	0.00228	0.0263	CbGeAlD
Zidovudine—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.00222	0.0256	CbGeAlD
Zidovudine—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0209	CcSEcCtD
Zidovudine—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.0202	CcSEcCtD
Zidovudine—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.0187	CcSEcCtD
Zidovudine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.018	CcSEcCtD
Zidovudine—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.0174	CcSEcCtD
Zidovudine—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.0017	0.0196	CbGeAlD
Zidovudine—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.00169	0.0195	CbGeAlD
Zidovudine—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.0166	CcSEcCtD
Zidovudine—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0162	CcSEcCtD
Zidovudine—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0161	CcSEcCtD
Zidovudine—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0154	CcSEcCtD
Zidovudine—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.0015	0.0683	CbGpPWpGaD
Zidovudine—ABCC4—kidney—focal segmental glomerulosclerosis	0.0015	0.0172	CbGeAlD
Zidovudine—SLC22A8—kidney—focal segmental glomerulosclerosis	0.00148	0.0171	CbGeAlD
Zidovudine—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.0147	CcSEcCtD
Zidovudine—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.00146	0.0168	CbGeAlD
Zidovudine—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0144	CcSEcCtD
Zidovudine—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.00144	0.0167	CbGeAlD
Zidovudine—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0139	CcSEcCtD
Zidovudine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0138	CcSEcCtD
Zidovudine—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.0133	CcSEcCtD
Zidovudine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0131	CcSEcCtD
Zidovudine—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0125	CcSEcCtD
Zidovudine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0121	CcSEcCtD
Zidovudine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0119	CcSEcCtD
Zidovudine—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.0012	0.0138	CbGeAlD
Zidovudine—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00109	0.0125	CbGeAlD
Zidovudine—TERT—Regulation of Telomerase—WT1—focal segmental glomerulosclerosis	0.00107	0.0487	CbGpPWpGaD
Zidovudine—TERT—Extension of Telomeres—PCNA—focal segmental glomerulosclerosis	0.00107	0.0487	CbGpPWpGaD
Zidovudine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0105	CcSEcCtD
Zidovudine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0101	CcSEcCtD
Zidovudine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000971	0.00962	CcSEcCtD
Zidovudine—TERT—TGF-beta Signaling Pathway—PIAS1—focal segmental glomerulosclerosis	0.000955	0.0434	CbGpPWpGaD
Zidovudine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000929	0.0092	CcSEcCtD
Zidovudine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000911	0.00902	CcSEcCtD
Zidovudine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000905	0.00896	CcSEcCtD
Zidovudine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000869	0.00861	CcSEcCtD
Zidovudine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000858	0.0085	CcSEcCtD
Zidovudine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00084	0.00833	CcSEcCtD
Zidovudine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000812	0.00804	CcSEcCtD
Zidovudine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.008	CcSEcCtD
Zidovudine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.008	CcSEcCtD
Zidovudine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00079	0.00782	CcSEcCtD
Zidovudine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000783	0.00776	CcSEcCtD
Zidovudine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000781	0.00774	CcSEcCtD
Zidovudine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000777	0.0077	CcSEcCtD
Zidovudine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000745	0.00738	CcSEcCtD
Zidovudine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000743	0.00737	CcSEcCtD
Zidovudine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000738	0.00731	CcSEcCtD
Zidovudine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000735	0.00847	CbGeAlD
Zidovudine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000734	0.00727	CcSEcCtD
Zidovudine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000731	0.00724	CcSEcCtD
Zidovudine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.00722	CcSEcCtD
Zidovudine—SLC28A1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000717	0.0326	CbGpPWpGaD
Zidovudine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00067	0.00664	CcSEcCtD
Zidovudine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.00661	CcSEcCtD
Zidovudine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000651	0.00645	CcSEcCtD
Zidovudine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.00641	CcSEcCtD
Zidovudine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000638	0.00632	CcSEcCtD
Zidovudine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000635	0.00629	CcSEcCtD
Zidovudine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000634	0.00628	CcSEcCtD
Zidovudine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000629	0.00623	CcSEcCtD
Zidovudine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000622	0.00616	CcSEcCtD
Zidovudine—TERT—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000615	0.028	CbGpPWpGaD
Zidovudine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.00601	CcSEcCtD
Zidovudine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0006	0.00595	CcSEcCtD
Zidovudine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.000599	0.0272	CbGpPWpGaD
Zidovudine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000598	0.00593	CcSEcCtD
Zidovudine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000592	0.00683	CbGeAlD
Zidovudine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000591	0.00586	CcSEcCtD
Zidovudine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000584	0.0266	CbGpPWpGaD
Zidovudine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000584	0.00578	CcSEcCtD
Zidovudine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.00576	CcSEcCtD
Zidovudine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000579	0.00574	CcSEcCtD
Zidovudine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000565	0.0056	CcSEcCtD
Zidovudine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.00556	CcSEcCtD
Zidovudine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000551	0.00546	CcSEcCtD
Zidovudine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000551	0.00546	CcSEcCtD
Zidovudine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000551	0.00546	CcSEcCtD
Zidovudine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000549	0.00544	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000547	0.00542	CcSEcCtD
Zidovudine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000544	0.00539	CcSEcCtD
Zidovudine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000533	0.00528	CcSEcCtD
Zidovudine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000528	0.00523	CcSEcCtD
Zidovudine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000528	0.00523	CcSEcCtD
Zidovudine—ABCB1—kidney—focal segmental glomerulosclerosis	0.000521	0.006	CbGeAlD
Zidovudine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.00513	CcSEcCtD
Zidovudine—ABCC4—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000518	0.0235	CbGpPWpGaD
Zidovudine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00512	CcSEcCtD
Zidovudine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.00508	CcSEcCtD
Zidovudine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000511	0.00506	CcSEcCtD
Zidovudine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000507	0.00584	CbGeAlD
Zidovudine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00499	CcSEcCtD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000493	0.0224	CbGpPWpGaD
Zidovudine—TERT—Telomere Maintenance—PCNA—focal segmental glomerulosclerosis	0.000486	0.0221	CbGpPWpGaD
Zidovudine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.00477	CcSEcCtD
Zidovudine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000478	0.00473	CcSEcCtD
Zidovudine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.0047	CcSEcCtD
Zidovudine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000471	0.00467	CcSEcCtD
Zidovudine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00047	0.00465	CcSEcCtD
Zidovudine—TERT—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000466	0.0212	CbGpPWpGaD
Zidovudine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000465	0.00461	CcSEcCtD
Zidovudine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000459	0.00455	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000456	0.00452	CcSEcCtD
Zidovudine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000455	0.00451	CcSEcCtD
Zidovudine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.00448	CcSEcCtD
Zidovudine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.00448	CcSEcCtD
Zidovudine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.00431	CcSEcCtD
Zidovudine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000432	0.00428	CcSEcCtD
Zidovudine—ABCC4—Ectoderm Differentiation—PODXL—focal segmental glomerulosclerosis	0.000426	0.0194	CbGpPWpGaD
Zidovudine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00042	0.00416	CcSEcCtD
Zidovudine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.00414	CcSEcCtD
Zidovudine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.00414	CcSEcCtD
Zidovudine—TERT—Chromosome Maintenance—PCNA—focal segmental glomerulosclerosis	0.000405	0.0184	CbGpPWpGaD
Zidovudine—TK1—E2F transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000401	0.0182	CbGpPWpGaD
Zidovudine—TERT—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000393	0.0179	CbGpPWpGaD
Zidovudine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000379	0.00375	CcSEcCtD
Zidovudine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000374	0.0037	CcSEcCtD
Zidovudine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.00358	CcSEcCtD
Zidovudine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000349	0.00346	CcSEcCtD
Zidovudine—TERT—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—focal segmental glomerulosclerosis	0.000343	0.0156	CbGpPWpGaD
Zidovudine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.00333	CcSEcCtD
Zidovudine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000333	0.0033	CcSEcCtD
Zidovudine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000333	0.0033	CcSEcCtD
Zidovudine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000331	0.00328	CcSEcCtD
Zidovudine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.00311	CcSEcCtD
Zidovudine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000309	0.014	CbGpPWpGaD
Zidovudine—TK1—Validated targets of C-MYC transcriptional activation—MMP9—focal segmental glomerulosclerosis	0.000288	0.0131	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—FN1—focal segmental glomerulosclerosis	0.000271	0.0123	CbGpPWpGaD
Zidovudine—TERT—Validated targets of C-MYC transcriptional activation—MMP9—focal segmental glomerulosclerosis	0.00026	0.0118	CbGpPWpGaD
Zidovudine—TERT—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—focal segmental glomerulosclerosis	0.000258	0.0117	CbGpPWpGaD
Zidovudine—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000254	0.0115	CbGpPWpGaD
Zidovudine—TERT—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	0.000242	0.011	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000234	0.0106	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.00023	0.0104	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000223	0.0101	CbGpPWpGaD
Zidovudine—SLC28A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000189	0.00861	CbGpPWpGaD
Zidovudine—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000169	0.00767	CbGpPWpGaD
Zidovudine—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000155	0.00704	CbGpPWpGaD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000154	0.00702	CbGpPWpGaD
Zidovudine—SLC28A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000154	0.007	CbGpPWpGaD
Zidovudine—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000149	0.00679	CbGpPWpGaD
Zidovudine—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000147	0.00669	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000142	0.00647	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000138	0.00626	CbGpPWpGaD
Zidovudine—SLC29A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000125	0.0057	CbGpPWpGaD
Zidovudine—ABCC4—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.000123	0.00561	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000118	0.00538	CbGpPWpGaD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.000118	0.00535	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00011	0.00502	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.00011	0.00501	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000104	0.00474	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000104	0.00472	CbGpPWpGaD
Zidovudine—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000103	0.00468	CbGpPWpGaD
Zidovudine—ABCC4—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.000103	0.00467	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000103	0.00467	CbGpPWpGaD
Zidovudine—ABCC4—Platelet degranulation—ALB—focal segmental glomerulosclerosis	0.000103	0.00466	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000102	0.00462	CbGpPWpGaD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	9.79e-05	0.00445	CbGpPWpGaD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—focal segmental glomerulosclerosis	9.77e-05	0.00444	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	9.21e-05	0.00419	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	8.79e-05	0.00399	CbGpPWpGaD
Zidovudine—TK1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.6e-05	0.00391	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	8.6e-05	0.00391	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	8.58e-05	0.0039	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	7.92e-05	0.0036	CbGpPWpGaD
Zidovudine—SLC28A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.82e-05	0.00356	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	7.6e-05	0.00346	CbGpPWpGaD
Zidovudine—TK1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.57e-05	0.00344	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	7.44e-05	0.00338	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.09e-05	0.00322	CbGpPWpGaD
Zidovudine—TK1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.97e-05	0.00317	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	6.72e-05	0.00306	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	6.66e-05	0.00303	CbGpPWpGaD
Zidovudine—ABCC4—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	6.48e-05	0.00295	CbGpPWpGaD
Zidovudine—SLC29A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.38e-05	0.0029	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	6.37e-05	0.0029	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.31e-05	0.00287	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.27e-05	0.00285	CbGpPWpGaD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	6.18e-05	0.00281	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	6.1e-05	0.00277	CbGpPWpGaD
Zidovudine—ABCC5—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	5.78e-05	0.00263	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TRPC6—focal segmental glomerulosclerosis	5.68e-05	0.00258	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	5.67e-05	0.00258	CbGpPWpGaD
Zidovudine—TERT—Disease—LPL—focal segmental glomerulosclerosis	5.67e-05	0.00258	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	5.64e-05	0.00256	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	5.59e-05	0.00254	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	5.48e-05	0.00249	CbGpPWpGaD
Zidovudine—SLC22A11—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	5.46e-05	0.00248	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	5.42e-05	0.00246	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	5.36e-05	0.00243	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	5.32e-05	0.00242	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.27e-05	0.0024	CbGpPWpGaD
Zidovudine—TK1—Metabolism—LPL—focal segmental glomerulosclerosis	5.25e-05	0.00239	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.13e-05	0.00233	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	4.98e-05	0.00227	CbGpPWpGaD
Zidovudine—SLC22A7—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	4.96e-05	0.00225	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.91e-05	0.00223	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.82e-05	0.00219	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	4.75e-05	0.00216	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—GNAQ—focal segmental glomerulosclerosis	4.75e-05	0.00216	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	4.65e-05	0.00211	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	4.56e-05	0.00207	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	4.55e-05	0.00207	CbGpPWpGaD
Zidovudine—TK1—Metabolism—AGT—focal segmental glomerulosclerosis	4.49e-05	0.00204	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	4.43e-05	0.00201	CbGpPWpGaD
Zidovudine—TERT—Disease—NOS2—focal segmental glomerulosclerosis	4.43e-05	0.00201	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	4.31e-05	0.00196	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.28e-05	0.00195	CbGpPWpGaD
Zidovudine—UGT2B7—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	4.26e-05	0.00194	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	4.17e-05	0.00189	CbGpPWpGaD
Zidovudine—SLC22A8—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	4.17e-05	0.00189	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.09e-05	0.00186	CbGpPWpGaD
Zidovudine—ABCC4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	4.01e-05	0.00182	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.97e-05	0.0018	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.76e-05	0.00171	CbGpPWpGaD
Zidovudine—TERT—Disease—SERPINE1—focal segmental glomerulosclerosis	3.73e-05	0.00169	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.6e-05	0.00164	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	3.59e-05	0.00163	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.57e-05	0.00162	CbGpPWpGaD
Zidovudine—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	3.48e-05	0.00158	CbGpPWpGaD
Zidovudine—TK1—Metabolism—ALB—focal segmental glomerulosclerosis	3.44e-05	0.00157	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—LIPC—focal segmental glomerulosclerosis	3.42e-05	0.00156	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.39e-05	0.00154	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.14e-05	0.00143	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CTGF—focal segmental glomerulosclerosis	3.01e-05	0.00137	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	2.93e-05	0.00133	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.93e-05	0.00133	CbGpPWpGaD
Zidovudine—SLC22A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	2.9e-05	0.00132	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	2.88e-05	0.00131	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.87e-05	0.0013	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—FN1—focal segmental glomerulosclerosis	2.82e-05	0.00128	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	2.8e-05	0.00127	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NOS2—focal segmental glomerulosclerosis	2.79e-05	0.00127	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.78e-05	0.00126	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.78e-05	0.00126	CbGpPWpGaD
Zidovudine—CYP2A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.67e-05	0.00121	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.61e-05	0.00119	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	2.6e-05	0.00118	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	2.57e-05	0.00117	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	2.52e-05	0.00115	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.52e-05	0.00114	CbGpPWpGaD
Zidovudine—ABCC5—Disease—LPL—focal segmental glomerulosclerosis	2.49e-05	0.00113	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	2.48e-05	0.00113	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.42e-05	0.0011	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.41e-05	0.0011	CbGpPWpGaD
Zidovudine—TERT—Disease—TGFB1—focal segmental glomerulosclerosis	2.35e-05	0.00107	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	2.35e-05	0.00107	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—ALB—focal segmental glomerulosclerosis	2.34e-05	0.00107	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.22e-05	0.00101	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	2.22e-05	0.00101	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.16e-05	0.000984	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	2.15e-05	0.000976	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.13e-05	0.00097	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.12e-05	0.000965	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.12e-05	0.000962	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—LPL—focal segmental glomerulosclerosis	2.09e-05	0.00095	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	2.06e-05	0.000937	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.05e-05	0.000931	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.03e-05	0.000923	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2e-05	0.000909	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.97e-05	0.000897	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.95e-05	0.000886	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NOS2—focal segmental glomerulosclerosis	1.95e-05	0.000886	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.91e-05	0.000866	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AGT—focal segmental glomerulosclerosis	1.79e-05	0.000812	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.77e-05	0.000803	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.74e-05	0.000791	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.74e-05	0.00079	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.72e-05	0.000783	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.65e-05	0.000749	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SERPINE1—focal segmental glomerulosclerosis	1.64e-05	0.000746	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.58e-05	0.000719	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	1.54e-05	0.0007	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.53e-05	0.000696	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.52e-05	0.000689	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.49e-05	0.000677	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.48e-05	0.000674	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.48e-05	0.000673	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.47e-05	0.00067	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.47e-05	0.000669	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.41e-05	0.000642	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.4e-05	0.000635	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.39e-05	0.000633	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ALB—focal segmental glomerulosclerosis	1.37e-05	0.000623	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.32e-05	0.0006	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	1.32e-05	0.000599	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.3e-05	0.000592	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.28e-05	0.000583	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.28e-05	0.000583	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	1.28e-05	0.000581	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.27e-05	0.000575	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.26e-05	0.000574	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.26e-05	0.000572	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.2e-05	0.000547	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.13e-05	0.000514	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	1.08e-05	0.000491	CbGpPWpGaD
Zidovudine—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	1.07e-05	0.000488	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.06e-05	0.000483	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	1.06e-05	0.000483	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.05e-05	0.000478	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TGFB1—focal segmental glomerulosclerosis	1.04e-05	0.000471	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.03e-05	0.000468	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	1.01e-05	0.00046	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	9.71e-06	0.000442	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—LPL—focal segmental glomerulosclerosis	9.65e-06	0.000439	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	9.64e-06	0.000438	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	9.51e-06	0.000432	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	9.45e-06	0.00043	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	9.41e-06	0.000428	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	9.08e-06	0.000413	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AGT—focal segmental glomerulosclerosis	8.99e-06	0.000409	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	8.79e-06	0.000399	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.76e-06	0.000398	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.71e-06	0.000396	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	8.67e-06	0.000394	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	8.48e-06	0.000386	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	8.28e-06	0.000376	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AGT—focal segmental glomerulosclerosis	8.25e-06	0.000375	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.05e-06	0.000366	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.9e-06	0.000359	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.82e-06	0.000355	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	7.74e-06	0.000352	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.63e-06	0.000347	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.13e-06	0.000324	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	6.97e-06	0.000317	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ALB—focal segmental glomerulosclerosis	6.9e-06	0.000314	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.71e-06	0.000305	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	6.59e-06	0.0003	CbGpPWpGaD
Zidovudine—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	6.55e-06	0.000298	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ALB—focal segmental glomerulosclerosis	6.33e-06	0.000288	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	5.88e-06	0.000267	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	5.79e-06	0.000263	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	5.74e-06	0.000261	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	5.64e-06	0.000256	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	5.6e-06	0.000255	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	5.36e-06	0.000244	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	5.1e-06	0.000232	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	5.03e-06	0.000229	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	4.91e-06	0.000223	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.7e-06	0.000214	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	4.59e-06	0.000209	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	4.33e-06	0.000197	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	3.86e-06	0.000176	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3.77e-06	0.000171	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	3.54e-06	0.000161	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	3.52e-06	0.00016	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	3.03e-06	0.000138	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	2.32e-06	0.000106	CbGpPWpGaD
